BSIM Therapeutics
Company
Primary tabs
About your organization / profile
Accelerator Application
BSIM Therapeutics is a biotech company focused on the design of organ-targeted, high-quality drug candidates for the treatment of life-threatening transthyretin-mediated amyloidoses (ATTR). We work closely with patients and physicians to understand and answer to multiple clinical manifestations of these pathologies which represent unmet medical needs.
Network (0)
There are no organizations in the network.
There are currently no users in this organisation.
